Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)

    Forecasted

    This grant supports research to improve cancer prevention, diagnosis, and treatment for American Indian and Alaska Native populations, especially in rural areas.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)

    This grant funds research to develop, adapt, or test culturally appropriate health interventions aimed at reducing disease and improving health among Native American populations.

    HHS-NIH11Due Jan 7, 2027$450,000

    Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)

    This grant funds planning and pilot research, co-developed with community partners, to develop and test interventions that improve health and reduce disparities for Native Hawaiian and Pacific Islander populations.

    HHS-NIH11Forecasted Feb 16, 2027$3,000,000Forecasted

    Native American Research Centers for Health (NARCH)

    This grant supports federally recognized Tribes and Tribal organizations in conducting health research, building research careers, and enhancing research infrastructure.

    HHS-NIH11Forecasted Jul 8, 2027Forecasted

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    Explore existing data to uncover cancer risk insights, seeking to understand outcomes like survival and treatment response.

    HHS-NIH11Due Nov 5, 2026· 10d$1,750,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 15d$150,000